Evaluation of once daily dose of phenylpropanolamine in the treatment of urethral sphincter mechanism incompetence in spayed bitches

Summary: The aim of this study was to evaluate the efficacy and long term safety of once daily administration of phenylpropanolamine (PPA) in the treatment of urethral sphincter mechanism incompetence (USMI) in spayed bitches in comparison to three times daily administrations. For this purpose, 22 spayed bitches suffering from USMI received either PPA at the dose rate of 1.5 mg/kg, body weight (BW) once daily (group I, n=11) or 1.5 mg/kg three times daily (group II, n=11) by oral administration. Clinical efficacy was determined by using a scoring system based on analysing the frequency and the amount of unconscious urination on d 7, 14 and 28. There was no significant difference (p>0.05) between the clinical response observed on d 7, 14 and 28 of treatment in group I and II. Eight dogs (72.7%) in each group were continent on d 28. The side effects observed were mild and transient. Phenylpropanolamine therapy was continued in 13 dogs that became continent after 28 d and the dogs were followed up for 12 months. None of the dogs showed symptoms of urinary incontinence except for 2 bitches that became refractory to PPA treatment in group II. Phenylpropanolamine was combined with estriol for 14 d (1 mg/dog PO) in dogs in which PPA therapy was inefficient or unsatisfactory on d 28 and in dogs that became refractory to PPA treatment. A total of 8 dogs were treated with estriol PPA combination. Five (62.5%) bitches were continent on 14 th d of estriol PPA combination treatment. In one bitch (12.5%) urinary incontinence improved. In conclusion, once daily administration of PPA at a dose of 1.5 mg/kg, BW is effective in treatment of USMI in spayed bitches and it offers a cheap and convenient treatment option. In addition, recurrence of incontinence can be observed during long term administration of PPA and combination of PPA with estriol is effective in dogs in which PPA therapy alone is unsatisfactory and in dogs that become refractory to PPA treatment.

[1]  L. Massart,et al.  Urodynamic and haemodynamic effects of a single oral administration of ephedrine or phenylpropanolamine in continent female dogs. , 2012, Veterinary journal.

[2]  F. Wagenlehner,et al.  Antimicrobial therapy of urinary tract infections. , 2011, International journal of antimicrobial agents.

[3]  A. Hamaide,et al.  Clinical evaluation of a single daily dose of phenylpropanolamine in the treatment of urethral sphincter mechanism incompetence in the bitch. , 2011, The Canadian veterinary journal = La revue veterinaire canadienne.

[4]  C. Cambier,et al.  Combined pharmacokinetic and urodynamic study of the effects of oral administration of phenylpropanolamine in female Beagle dogs. , 2010, Veterinary journal.

[5]  I. Reichler,et al.  Urethral sphincter mechanism incompetence in spayed bitches: new insights into the pathophysiology and options for treatment. , 2008 .

[6]  F. Snaps,et al.  Urodynamic and morphologic changes in the lower portion of the urogenital tract after administration of estriol alone and in combination with phenylpropanolamine in sexually intact and spayed female dogs. , 2006, American journal of veterinary research.

[7]  F. Farnir,et al.  Evaluation of the urodynamic and hemodynamic effects of orally administered phenylpropanolamine and ephedrine in female dogs. , 2006, American journal of veterinary research.

[8]  B. Bülent,et al.  Effectiveness of different pharmacological approaches on post-ovariohysterectomy urinary incontinence in the bitch , 2005 .

[9]  I. de Francesco,et al.  Urinary Incontinence After Spaying in the Bitch: Incidence and Oestrogen-therapy , 2004, Veterinary Research Communications.

[10]  P. Mandigers,et al.  Treatment of bitches with acquired urinary incontinence with oestriol , 2001, Veterinary Record.

[11]  P. Hensel,et al.  Influence of phenylpropanolamine and ephedrine on urethral closure pressure and arterial blood pressure of spayed bitches. , 2000 .

[12]  D. Laflamme.  Development and validation of a body condition score system for dogs , 1997 .

[13]  S. Arnold.  [Urinary incontinence in castrated bitches. 2. Diagnosis and treatment]. , 1997, Schweizer Archiv fur Tierheilkunde.

[14]  H. Bostedt,et al.  [Urinary incontinence in castrated female dogs. 2. Therapy]. , 1995, Tierarztliche Praxis.

[15]  S. Gregory,et al.  Developments in the understanding of the pathophysiology of urethral sphincter mechanism in competence in the bitch. , 1994, The British veterinary journal.

[16]  R. White,et al.  Phenylpropanolamine: an alpha-adrenergic agent for the management of urinary incontinence in the bitch associated with urethral sphincter mechanism incompetence , 1989, Veterinary Record.

[17]  M. Hubler,et al.  [Urinary incontinence in spayed female dogs: frequency and breed disposition]. , 1989, Schweizer Archiv fur Tierheilkunde.

[18]  M. Lindskog,et al.  Estrogens and phenylpropanolamine in combination for stress urinary incontinence in postmenopausal women. , 1989, Urology.

[19]  P. Holt.  Urinary incontinence in the bitch due to sphincter mechanism incompetence: prevalence in referred dogs and retrospective analysis of sixty cases , 1985 .

[20]  K. Creed,et al.  The effects of oestrogens on spontaneous activity and responses to phenylephrine of the mammalian urethra. , 1985, The Journal of physiology.

[21]  K. Creed.  Effect of hormones on urethral sensitivity to phenylephrine in normal and incontinent dogs. , 1983, Research in veterinary science.

[22]  Awad Sa,et al.  The effect of adrenergic drugs and hypogastric nerve stimulation on the canine urethra. A radiologic and urethral pressure study. , 1976 .

[23]  S. Awad,et al.  The effect of adrenergic drugs and hypogastric nerve stimulation on the canine urethra. A radiologic and urethral pressure study. , 1976, Investigative urology.

[24]  F. B. Scott,et al.  Treatment of urinary incontinence by an implantable prosthetic urinary sphincter. , 2002, The Journal of urology.